Wiener Gesundheitsverbund

Vienna 1210

2 studies enrolling now · 2 studies all time

What they study most

Anaplastic Lymphoma Kinase-positive, Interstitial Lung Diseases, Non-small Cell Lung Cancer

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression — Starting soon